Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23264960 | 0.85 | — | — | |
| SCHEMBL429456 | 0.85 | — | — | |
| SCHEMBL22661254 | 0.85 | — | — | |
| SCHEMBL23005879 | 0.85 | — | — | |
| SCHEMBL2660158 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL7994392 | 0.83 | — | — | |
| Ethylene SCHEMBL8982169 | 0.80 | MAPT (0.31) | POLB | |
| SCHEMBL28052632 | 0.78 | — | — | |
| SCHEMBL22813241 | 0.72 | — | — | |
| SCHEMBL1266409 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4353758-A1 | RESIN COMPOSITION, COATING MATERIAL, AND COATED ARTICLE | DIC Corporation (JP) | 2024-04-17 | — | — | EP | disclosed |
| EP-2708527-B1 | ALDEHYDE COMPOUND PRODUCTION METHOD | MITSUI CHEMICALS INC (JP) | 2019-03-20 | — | — | EP | disclosed |
| US-9227925-B2 | Process for producing aldehyde compounds | MITSUI CHEMICALS, INC. (JP) | 2016-01-05 | — | — | US | disclosed |
| US-20140088321-A1 | PROCESS FOR PRODUCING ALDEHYDE COMPOUNDS | MITSUI CHEMICALS, INC. (JP) | 2014-03-27 | — | — | US | disclosed |
| EP-2708527-A1 | ALDEHYDE COMPOUND PRODUCTION METHOD | Mitsui Chemicals, Inc. (JP) | 2014-03-19 | — | — | EP | disclosed |
| US-8414979-B2 | Radiation-curable resin composition, radiation-curable coating material, and method for forming protective layer | DIC CORPORATION (JP) | 2013-04-09 | — | — | US | disclosed |
| US-20100104765-A1 | RADIATION-CURABLE RESIN COMPOSITION, RADIATION-CURABLE COATING MATERIAL, AND METHOD FOR FORMING PROTECTIVE LAYER | DIC CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
| EP-2133374-A1 | ACTIVE ENERGY RAY-CURABLE RESIN COMPOSITION, ACTIVE ENERGY RAY-CURABLE COATING MATERIAL, AND METHOD FOR FORMING PROTECTIVE LAYER | DIC Corporation (JP) | 2009-12-16 | — | — | EP | disclosed |
| JP-2006143991-A | AQUEOUS POLYURETHANE RESIN AND LAMINATED FILM | MITSUI CHEMICALS POLYURETHANES INC | 2006-06-08 | — | — | JP | disclosed |
| US-6710151-B2 | DECREASED OCCURRENCE OF A VOLATILE COMPONENT IN THE CURING STAGE, POWDER COATING | MITSUI CHEMICALS, INC. (JP) | 2004-03-23 | — | — | US | disclosed |
| US-20030162930-A1 | Terminal-blocked isocyanate prepolymer having oxadiazine ring, process for producing the same, and composition for surface-coating material | MITSUI CHEMICALS, INC. (JP) | 2003-08-28 | — | — | US | disclosed |
| EP-1291372-A1 | TERMINAL-BLOCKED ISOCYANATE PREPOLYMER HAVING OXADIAZINE RING, PROCESS FOR PRODUCING THE SAME, AND COMPOSITION FOR SURFACE-COATING MATERIAL | Mitsui Chemicals, Inc. (JP) | 2003-03-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140088321-A1 | PROCESS FOR PRODUCING ALDEHYDE COMPOUNDS | ALDH1A1, ALDH1B1, ALDH5A1 | POLB 970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.